Literature DB >> 23268316

Low-grade adenosquamous carcinoma of the breast.

Kailing Soo1, Puay Hoon Tan.   

Abstract

Low-grade adenosquamous carcinoma is a rare and unique form of invasive mammary carcinoma. Though it is categorised as a variant of metaplastic carcinoma, it differs from its counterparts in this heterogeneous category by its relative clinical indolence, also reflected histologically in its low-grade cytomorphology. Descriptions of such a tumour were reported as early as 1912. However, low-grade adenosquamous carcinoma was only formally recognised in 1987 with the publication of Rosen and Ernsberger's landmark paper. Since then, several case reports and larger series have reaffirmed the clinicopathological characteristics of this unusual and uncommon tumour. Due to its rarity, however, many aspects of low-grade adenosquamous carcinoma, including its immunohistochemical and genetic profiles, remain unclear. This paper reviews the literature on this entity from 1987 to date, summarising its clinical and pathological features, and highlighting the diagnostic challenges it poses.

Entities:  

Keywords:  Breast; Immunohistochemistry; Metaplasia

Mesh:

Year:  2012        PMID: 23268316     DOI: 10.1136/jclinpath-2012-201084

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.

Authors:  Dejan Maglic; Daniel B Stovall; J Mark Cline; Elizabeth A Fry; Ali Mallakin; Pankaj Taneja; David L Caudell; Mark C Willingham; Guangchao Sui; Kazushi Inoue
Journal:  J Pathol       Date:  2015-02-09       Impact factor: 7.996

Review 2.  [Differential diagnosis of spindle cell tumors of the breast from biopsy material].

Authors:  F Länger; M Christgen; H H Kreipe
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

Review 3.  Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management.

Authors:  Emad A Rakha; Sunil Badve; Vincenzo Eusebi; Jorge S Reis-Filho; Stephen B Fox; David J Dabbs; Thomas Decker; Zsolt Hodi; Shu Ichihara; Andrew H S Lee; José Palacios; Andrea L Richardson; Anne Vincent-Salomon; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Ian O Ellis
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

Review 4.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

5.  Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases.

Authors:  Xue Chao; Wanlin Tan; Julia Y Tsang; Gary M Tse; Jintao Hu; Ping Li; Jinghui Hou; Mei Li; Jiehua He; Peng Sun
Journal:  Breast Cancer       Date:  2021-05-03       Impact factor: 4.239

6.  A population-based analysis of adenosquamous carcinoma of the salivary gland.

Authors:  Hui Han; Xiao-Ding Luo; Lin-Qin Shao
Journal:  Gland Surg       Date:  2021-02

Review 7.  Adenosquamous carcinoma of the ampulla of Vater: a case report and literature review.

Authors:  Sojun Hoshimoto; Koichi Aiura; Masaya Shito; Toshihiro Kakefuda; Hitoshi Sugiura
Journal:  World J Surg Oncol       Date:  2015-09-29       Impact factor: 2.754

8.  Expression of hormone receptors in low-grade adenosquamous carcinoma of the breast: A case report.

Authors:  Hai-Bo Wu; An-Li Zhang; Wei Wang; Heng Li
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

Review 9.  Breast carcinomas of low malignant potential.

Authors:  Stuart J Schnitt; Falko Fend; Thomas Decker
Journal:  Virchows Arch       Date:  2021-07-22       Impact factor: 4.064

10.  Bilateral synchronous low-grade adenosquamous carcinoma of the breast: A Case report with review of the current literature.

Authors:  J L Senger; P Meiers; R Kanthan
Journal:  Int J Surg Case Rep       Date:  2015-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.